|Articles|April 30, 2004
AMO buys Pfizer's surgical ophthalmology unit
Advanced Medical Optics Inc. (AMO) brought something special to San Diegofor this week's American Society of Cataract and Refractive Surgery meeting-thesurgical ophthalmology business formerly owned by Pfizer. AMO and Pfizer on April 21 entered into a definitive agreement for AMO to acquire Pfizer's surgical ophthalmology business for $450 million in cash.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
4DMT releases positive interim 1.5- to 3.5-year data from phase 1/2 PRISM trial
2
Q&A: Karolinne M. Rocha discusses the IOL and patient tolerance of residual astigmatism
3
Beyond The Walls: The “how and why” behind what drives today’s ophthalmologists
4
Study identifies 6 key genes linking air pollution to dry eye disease
5














































.png)


